Loading...
Thumbnail Image
Publication

Updates on radiotherapy-immunotherapy combinations: Proceedings of 6(th) annual ImmunoRad conference

Gregucci, F.
Spada, S.
Barcellos-Hoff, M. H.
Bhardwaj, N.
Hak, C. C. W.
Fiorentino, A.
Guha, C.
Guzman, M. L.
Harrington, K.
Herrera, F. G.
... show 10 more
Citations
Altmetric:
Abstract
Focal radiation therapy (RT) has attracted considerable attention as a combinatorial partner for immunotherapy (IT), largely reflecting a well-defined, predictable safety profile and at least some potential for immunostimulation. However, only a few RT-IT combinations have been tested successfully in patients with cancer, highlighting the urgent need for an improved understanding of the interaction between RT and IT in both preclinical and clinical scenarios. Every year since 2016, ImmunoRad gathers experts working at the interface between RT and IT to provide a forum for education and discussion, with the ultimate goal of fostering progress in the field at both preclinical and clinical levels. Here, we summarize the key concepts and findings presented at the Sixth Annual ImmunoRad conference.
Description
Date
2023
Publisher
Keywords
Type
Article
Citation
Gregucci F, Spada S, Barcellos-Hoff MH, Bhardwaj N, Hak CCW, Fiorentino A, et al. Updates on radiotherapy-immunotherapy combinations: Proceedings of 6(th) annual ImmunoRad conference. Oncoimmunology. 2023 Dec;12(1). PubMed PMID: WOS:001010242900001.
Journal Title
Journal ISSN
Volume Title
Embedded videos